Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 


Nutlin-based PROTAC targeting on BRD4
ENZ-CHM262-0005 5 mg 879.00 USD
ENZ-CHM262-0010 10 mg 1,226.00 USD
ENZ-CHM262-0025 25 mg 2,514.00 USD
Do you need bulk/larger quantities?
A1874 is a nutlin-based PROTAC targeting on BRD4, consist of a BRD4-ligand JQ1 linked to a MDM2 E3 ligase ligand RG7388. A1874 possesses dual function as it dose-dependently degraded its target BRD4, accompanied with the downregulation of c-MYC, as well as stabilization of P53 and upregulated P21 due to the efficient engagement of MDM2 by RG7388.

Product Details

Appearance:White solid.
Shipping:Shipped on Blue Ice
Long Term Storage:-20°C
Regulatory Status:RUO - Research Use Only
ENZ-CHM262 structure
Please mouse over
ENZ-CHM262 structure

General Literature References

MDM2-Recruiting PROTAC Offers Superior, Synergistic Antiproliferative Activity via Simultaneous Degradation of BRD4 and Stabilization of p53: J. Hines, et al.; Cancer Res. 79, 251 (2019), Abstract; Full Text

Related Literature

Ubiquitin & UBL Signaling Catalog
Ubiquitin & UBL Signaling Catalog
Download as PDF

All new literature pieces

Keep in touch

©2022 Enzo Life Sciences, Inc.,